UK Life Sciences Company Directory
Search and compare 1,500+ UK life sciences companies across biotech, biopharma, CROs, CDMOs, diagnostics, research tools and other specialist sectors by category, location and capability.
QIB Extra
Contract research and analytical services for food and health industries
QIB Extra is a wholly owned commercial subsidiary of Quadram Institute Bioscience, providing contract research, analytical services, and consultancy to companies in the food, nutrition, and health sectors. Operating from Norwich Research Park, it gives commercial clients access to the facilities and scientific…
Microneedle Solutions
Thermostable vaccine formulations delivered through microneedle patches
Microneedle Solutions is a biotechnology company developing vaccine-containing microneedle patches for self-administration. Its platform combines a patented needle-array manufacturing process with vaccine-loaded matrices intended to protect biological payloads and enable delivery through the skin. The company has…
Peptone
AI-driven drug discovery targeting intrinsically disordered proteins
Peptone is a translational biophysics company developing novel therapeutics against intrinsically disordered proteins (IDPs), a class of structurally dynamic proteins implicated in cancer, inflammation and metabolic disease. The company combines hydrogen-deuterium exchange mass spectrometry, high-performance…
Seda Pharmaceutical Development Services
Pharmaceutical development, clinical pharmacology and GMP manufacturing
Seda Pharmaceutical Development Services is a provider of integrated pharmaceutical development, clinical pharmacology and GMP manufacturing services to the pharma and biotech sectors. The company supports clients from early-stage drug development through clinical trials to regulatory approval, with particular…
Locate Bio
Controlled-release orthobiologics for spinal fusion and bone repair
Locate Bio is a clinical-stage biotechnology company developing a portfolio of orthobiologic products for musculoskeletal surgery. Its proprietary Programmed Drug Release platform encapsulates recombinant proteins within biodegradable polymer scaffolds to enable controlled, extended-release delivery. Lead product…
G&L Scientific
Regulatory affairs, quality assurance and clinical development consulting
G&L Scientific is a Belfast-founded regulatory affairs and quality assurance consultancy providing integrated product development and market access services to pharmaceutical, biopharmaceutical, and biotechnology clients globally. Services span CMC, clinical development, regulatory strategy and submissions,…
ILC Therapeutics
Engineered hybrid interferon therapeutics for viral and immune-mediated disease
ILC Therapeutics is a pre-clinical biotechnology company developing hybrid interferons, an engineered cytokine drug class combining favourable attributes of multiple naturally occurring interferon subtypes. The platform rationally designs novel candidates with reduced toxicity and pleiotropic activity across multiple…
Orion Microbiology
Contract microbiology testing and consultancy for industry and research
Orion Microbiology is a contract testing laboratory providing microbiological analysis, regulatory compliance testing, and consultancy services to pharmaceutical, cosmetics, veterinary, and environmental sectors. Operating from Sci-Tech Daresbury and adhering to ISO 17025 quality management principles, the company…
Alchemab Therapeutics
Antibody discovery platform identifying therapeutics from resilient individuals
Alchemab Therapeutics is a clinical-stage biopharmaceutical company developing antibody therapeutics for neurodegenerative diseases, oncology, and immunology. Its platform combines deep B cell sequencing and machine learning to identify naturally protective antibodies from individuals resilient to specific diseases.…
Vitamab
Sustainable conjugation technology for antibody-drug conjugate manufacturing
Vitamab is a Manchester-based biotechnology company developing conjugation technology to strengthen the antibody-drug conjugate manufacturing supply chain. Its proprietary system uses accessible, lower-toxicity materials in place of scarce or hazardous reagents, aiming to reduce production costs and environmental…
Sania Therapeutics
Gene therapy biotech targeting neural circuit dysfunction
Sania Therapeutics is a biotechnology company developing genetic medicines for diseases caused by dysfunctional neural circuits. Its approach combines precision AAV delivery to selected neural circuits with tuneable neuromodulation, using human iPSC-derived neural models to direct the evolution of human-centric…
Enzyme Research Laboratories
High-purity blood coagulation enzymes and antibodies for research
Enzyme Research Laboratories is a Swansea-based manufacturer and supplier of high-purity coagulation reagents for haemostasis and thrombosis research. Its product range covers purified zymogens and activated enzymes derived from human and bovine plasma, alongside monoclonal and polyclonal antibodies against…
Newcleic
Developing cell-free long-DNA manufacturing for precision breeding
Newcleic develops cell-free methods for manufacturing long DNA sequences, drawing on biochemical engineering research at UCL. Its technology aims to make complex DNA production more reliable, accessible and sustainable. Its initial focus is agricultural biotechnology, supporting precision breeding and plant…
BRAINCURES
Systems biology platform for brain disease drug discovery and repurposing
BRAINCURES is a computational biotechnology company applying a systems biology approach to drug discovery for brain diseases, including Alzheimer's disease, depression, epilepsy, pain and schizophrenia. Its platform maps molecular relationships between compounds, genes and diseases, drawing on its own model of the…
ClotProtect Therapeutics
Novel small-molecule anti-fibrinolytic for acute traumatic and surgical bleeding
ClotProtect Therapeutics is a University of Leeds spin-out developing a first-in-class small molecule anti-fibrinolytic to address acute bleeding following trauma and surgery. The company's approach directly inhibits the enzyme responsible for blood clot breakdown, aiming to offer greater efficacy than current…
Pipeline Organics
Enzymatic biofuel cells generating renewable electricity from wastewater
Pipeline Organics is an industrial biotechnology company developing enzymatic fuel cell technology to generate renewable electricity from liquid organic waste. Its product uses enzyme biochemistry and 3D-printed cell architecture to convert the chemical potential of wastewater into continuous, low-carbon electricity.…
Enhanced Fertility
AI-powered fertility diagnostics and remote patient pathway platform
Enhanced Fertility is a digital health company providing software and at-home testing services for fertility diagnosis and treatment planning. The company's platform supports patients with remote biomarker testing and personalised fertility assessments, and offers clinics an AI-assisted portal for managing…
Laboratory Animal Science Association
Laboratory animal research standards, welfare and 3Rs guidance
Laboratory Animal Science Association is a scientific society supporting professionals involved in animal research and experimental models. It publishes practical guidance on animal welfare, ethical review, behavioural studies and training under UK legislation governing scientific animal use. Its specialist sections…
Prima Mente
AI epigenomics platform for neurodegenerative disease detection
Prima Mente is a biotechnology company developing large-scale biological foundation models to understand and detect neurodegenerative disease. The company generates proprietary multi-omic data including whole-epigenome sequencing, and trains transformer-based models on DNA methylation patterns in cell-free DNA to…
NWPharmaTech
Micellar oral cannabidiol formulation for psychiatric drug development
NWPharmaTech is a clinical-stage biotechnology company developing investigational oral cannabidiol formulations for psychiatric disorders. Its NWPT-SM32300 programme uses a high-loading micellar softgel intended to deliver consistent oral doses. The company reports completion of a Phase 1 pharmacokinetic and…